The University of Kent says the vaccination queue has "closed" for the day, but urged students to return for the jab tomorrow.
The number of meningitis cases has rose again, according to figures released by the UK Health Security Agency. Sky News ...
During a briefing Monday morning, Hochul urged calm amid the spread of Omicron and made clear that her ultimate goal is to avoid shutting down New York's economy and institutions, ...
RNA vaccines saved millions of lives during COVID-19 but have limitations like waning immunity and complex production. Scientists are now testing a new platform called DoriVac, which uses folded DNA ...
A fourth dose of bivalent or monovalent BA.1-adapted BNT162b2 vaccines was safe and elicited robust neutralizing responses in adults aged 18 to 55 years.
Topline data from 400-person sentinel cohort of the Phase 2b COVID-19 trial anticipated early Q2 2026Published positive clinical results in the ...
The COVID-19 pandemic brought messenger RNA (mRNA) vaccines to the forefront of global health care. After their clinical ...
A futuristic “DNA origami” vaccine platform may one day outperform mRNA shots while being easier to produce and distribute. Credit: Shutterstock Scientists have developed a new DNA origami–based ...
As the sixth anniversary of the WHO pandemic declaration passes with total media silence, wastewater data, excess death estimates and new research on Long COVID reveal an ongoing public health ...
A multi-disciplinary research team at the Wyss Institute at Harvard University, Dana-Farber Cancer Institute, and ...
Adults in England aged 50 years or older who received the bivalent BA.1 mRNA booster vaccine during the 2022 autumn campaign had substantially lower risks for COVID-related hospitalisation and death ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results